Andere Kunden interessierten sich auch für
![Ophthalmic Drug Delivery, 2nd Edition]( "Ophthalmic Drug Delivery, 2nd Edition")
Ophthalmic Drug Delivery, 2nd Edition101,99 €![Focus on Antibiotics]( "Focus on Antibiotics")
Focus on Antibiotics93,99 €![Slice of Life 2nd Edition]( "Slice of Life 2nd Edition")
Slice of Life 2nd Edition19,99 €![Fracture Classifications in Clinical Practice 2nd Edition]( "Fracture Classifications in Clinical Practice 2nd Edition")
Fracture Classifications in Clinical Practice 2nd Edition38,99 €![The Monster in Mummy (2nd Edition)]( "The Monster in Mummy (2nd Edition)")
The Monster in Mummy (2nd Edition)23,99 €![The Antimicrobial Drugs, 2nd Edition]( "The Antimicrobial Drugs, 2nd Edition")
The Antimicrobial Drugs, 2nd Edition103,99 €![Development, Characterization, and Application of Bioactive Peptides, Diagnostic Biomarkers, and Pharmaceutical Proteins]( "Development, Characterization, and Application of Bioactive Peptides, Diagnostic Biomarkers, and Pharmaceutical Proteins")
Development, Characterization, and Application of Bioactive Peptides, Diagnostic Biomarkers, and Pharmaceutical Proteins72,99 €
This Special Issue, "Focus on Antibiotics - New Challenges and Steps Forward in Discovery and Development, 2nd Edition," explores innovative strategies and groundbreaking research to combat antibiotic resistance. Key advancements include enhancing antibacterial drug potency, selectivity, and safety through five-membered heterocycles; using phytocannabinoids like cannabigerol for MRSA biofilm inhibition; employing ZnONPs and AuNPs to combat MDR pathogens; developing Bac10307-AgNPs with potent antibacterial and antioxidant properties; creating fluoroquinolone co-crystals with flavonoids for enhanced antimicrobial activity; synthesizing 6¿-deoxykanamycin A analogues to improve activity against resistant Staphylococcus aureus; designing silver nanocomposites with significant antibacterial and antibiofilm activity; utilizing the insect AMP Tricoplusia ni cecropin A for colistin-resistant Escherichia coli with low cytotoxicity; and enhancing antimicrobial and antiviral activity with peptide [des-Cys11,Lys12,Lys13-(p-BthTX-I)2K] derivatives. This Special Issue showcases collaborative efforts to address antibiotic resistance, inspiring further research and development.